Dr. Harry James Dounis, DO

Dr. Dounis practices at Freehold Dialysis in Neptune, New Jersey.

Dr. Dounis' NPI, 1124286083, was assigned on May 28, 2008. Dr. Dounis graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2005. Dr. Dounis holds New Jersey license 25MB08752800.

Dr. Dounis' primary practice is Freehold Dialysis, at 2100 Corlies Ave, Neptune, NJ 07753 in Monmouth County. The practice phone is (732) 303-1589.

Dr. Dounis' primary practice is Freehold Dialysis in Neptune, New Jersey. Dr. Dounis is also affiliated with Jersey Shore University Medical Center. The medical group on file is Hypertension & Nephrology Associates. Dmand AI also links Dr. Dounis to 3 more hospitals, 3 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dounis practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Dounis' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Dounis is board certified in internal medicine by the American Board of Internal Medicine. Dr. Dounis is licensed in New Jersey.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts, kidney disease and parathyroid gland disorder among the conditions Dr. Dounis treats.

CMS data shows 4,468 Medicare services from Dr. Dounis across 18 procedure codes in 2024, for 791 Medicare patients. Medicare paid $330,288 for them.

CMS counts 791 Medicare patients who saw Dr. Dounis in 2024. The largest group is 75 to 84, with 334 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dounis' median patient age at 73, with 39% women.

In 2024, Dr. Dounis wrote 2,938 Medicare Part D claims for 407 patients. 81% of them were for generic drugs. CMS names the drug for 2,607 of them, across 58 drugs with 11 or more claims each, at $608,543 in total drug cost. In 2023, CMS named 2,301 claims across 48 drugs.

Dr. Dounis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dounis as offering telehealth.

Dmand AI links 5 papers to Dr. Dounis, published from 2018 to 2019. 2018 was the busiest year, with 2. Dr. Dounis' most frequent co-authors are Michael Robert Levitt, MD, Eric Costanzo, DO and Gurpreet Singh Lamba, MBBS.

CMS Open Payments shows 252 general payments to Dr. Dounis from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Relypsa, Inc. paid the most, $76,911.

Dmand AI lists 1 award for Dr. Dounis, most recently CMS Stage 1 2012 in 2011.

Dr. Dounis graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2005.

Dr. Dounis is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.